<DOC>
	<DOCNO>NCT01880970</DOCNO>
	<brief_summary>The aim trial test efficacy infant formula contain synbiotics prevention gastro-intestinal infection .</brief_summary>
	<brief_title>Effect Starter Formula Infection Prevention</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Trematode Infections</mesh_term>
	<criteria>Healthy newborn infant Full term infant ( ≥ 37 week gestation ; ≤ 42 week gestation ) Age infant ≤ 13 day time enrollment Birth weight ≥ 2500g ≤ 4500g For FF group : The infant 's mother elect breastfeed For BF group : The infant 's mother elect fully breastfeed baby , enrollment least 3 month age Having obtain his/her legal representative 's informed consent Congenital illness malformation may affect normal growth ( especially immunodeficiency ) Significant prenatal and/or postnatal diseases Perinatal antibiotic infant antibiotic time inclusion Infants whose mother acute infection last month pregnancy Rehospitalisation 2 day first 14 day life ( exceptionally , infant rehospitalized jaundice may enrol study ) Receiving infant formula contain probiotic and/or prebiotics time enrollment Newborn whose parent / caregiver expect comply treatment Newborn currently participate another interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>